Zobrazeno 1 - 4
of 4
pro vyhledávání: '"D A SHASHELEVA"'
Autor:
D A SHASHELEVA, A A MASCHAN, L N SHELIKHOVA, U N PETROVA, E E KURNIKOVA, O I ILLARIONOVA, E V BOYAKOVA, G A NOVICHKOVA, M A MASCHAN
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 57-64 (2018)
The main goal is to optimize hematopoietic stem cell transplantation (HSCT) approach among adolescents and young adults with paroxysmal nocturnal hemoglobinuria (PNH) by means of Graft-versus-host disease (GVHD) and post-transplant complications risk
Externí odkaz:
https://doaj.org/article/c5aa744b838d4ea0acb3b3e7f77cb253
Autor:
M. A. Ilyushina, L. N. Shelikhova, D. A. Shasheleva, R. D. Khismatullina, S. L. Blagov, A. A. Maschan, M. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:32-41
Hematopoietic stem cell transplantation (HSCT) from an allogeneic donor is a standard treatment for high-risk leukemia that makes it possible to cure patients with chemotherapy-resistant leukemia. “Graft-versus-host” disease (GVHD) is the key bio
Autor:
M. A. Maschan, L. A. Khachatryan, Yu. V. Skvortsova, E. E. Kurnikova, D. A. Shasheleva, V. O. Bobrynina, D. N. Balashov, E. V. Skorobogatova, D. D. Baydildina, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 45-55 (2014)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the standard curative therapy for juvenile myelomonocytic leukemia (JMML). Seventeen patients with JMML received myeloablative conditioning (busulfan-based — 15, treosulfan-based — 2).
Externí odkaz:
https://doaj.org/article/6e4f8b1ded44412bbefc3903bad71016
Autor:
O I Illarionova, Larisa Shelikhova, Elena Kurnikova, Michael Maschan, E V Boyakova, Alexey Maschan, U.N. Petrova, G.A. Novichkova, D A Shasheleva
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 57-64 (2018)
The main goal is to optimize hematopoietic stem cell transplantation (HSCT) approach among adolescents and young adults with paroxysmal nocturnal hemoglobinuria (PNH) by means of Graft-versus-host disease (GVHD) and post-transplant complications risk